Canada Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

Published by: Global Markets Direct

Published: Sep. 30, 2008 - 150 Pages

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Definitions

2.2.1 Drug delivery devices

3 Healthcare Sector Review

3.1 Healthcare Expenditure

3.2 Healthcare Infrastructure

3.3 Healthcare Policy

4 Drug Delivery Devices in Canada

4.1 Drug Delivery Devices Overall Revenues (2000-2012)

4.2 Drug Delivery Devices Overall Volume (2000-2012)

4.3 Drug Delivery Devices Company Shares (2005-2006)

5 Inhalation Systems in Canada

5.1 Inhalation Systems Overall Revenues (2000-2012)

5.1.1 Metered Dose Inhalation Systems Overall Revenues (2000-2012)

5.1.2 Dry Powder Inhalation Systems Overall Revenues (2000-2012)

5.2 Inhalation Systems Overall Volume (2000-2012)

5.2.1 Metered Dose Inhalation Systems Overall Volume (2000-2012)

5.2.2 Dry Powder Inhalation Systems Overall Volume (2000-2012)

5.3 Inhalation Systems Average Price (2000-2012)

5.3.1 Metered Dose Inhalation Systems Average Price (2000-2012)

5.3.2 Dry Powder Inhalation Systems Average Price (2000-2012)

5.4 Inhalation Systems Distribution Share (2005-2006)

5.5 Inhalation Systems Company Share (2005-2006)

6 Infusion Systems in Canada

6.1 Infusion Systems Overall Revenues (2000-2012)

6.1.1 Infusion Pumps Infusion System Overall Revenue (2000-2012)

6.1.2 Syringe Pumps Infusion System Overall Revenue (2000-2012)

6.1.3 Infusion Disposable Sets Infusion System Overall Revenues (2000-2012)

6.2 Infusion Systems Overall Volume (2000-2012)

6.2.1 Infusion Pumps Overall Volume (2000-2012)

6.2.2 Syringe Pumps Overall Volume (2000-2012)

6.2.3 Infusion Disposable Sets Overall Volume (2000-2012)

6.3 Infusion Systems Average Price (2000-2012)

6.3.1 Infusion Pumps Average Price (2000-2012)

6.3.2 Syringe Pumps Average Price (2000-2012)

6.3.3 Infusion Disposable Sets Average Price (2000-2012)

6.4 Infusion Systems Distribution Share (2005-2006)

6.5 Infusion Systems Company Share (2005-2006)

7 Needle Free Injections in Canada

7.1 Needle Free Injections Overall Revenue (2000-2012)

7.2 Needle Free Injections Overall Volume (2000-2012)

7.3 Needle Free Injections Average Price (2000-2012)

7.4 Needle Free Injections Distribution Share (2005-2006)

7.5 Needle Free Injections Company Share (2005-2006)

8 AstraZeneca PLC Company Profile

8.1 Company Overview

8.2 Business Overview

8.2.1 Products

8.2.2 History

8.3 Locations And Subsidiaries

9 GlaxoSmithKline plc Company Profile

9.1 Company Overview

9.2 Business Overview

9.2.1 Products

9.2.2 History

9.3 Locations And Subsidiaries

10 3M Company Profile

10.1 Company Overview

10.2 Business Overview

10.2.1 Consumer and Office

10.2.2 Display and Graphics

10.2.3 Electro and Communications

10.2.4 Health Care

10.2.5 Industrial and Transportation

10.2.6 Safety, Security and Protection Services

10.2.7 Products

10.3 Value Chain Analysis

10.3.1 Manufacturing

10.3.2 Product Development

10.3.3 Sales and Marketing

10.4 SWOT Analysis

10.4.1 3M Company Strengths

3M Company Weaknesses

3M Company Opportunities

3M Company Threats

10.5 Financial and Operational Review

10.6 Locations And Subsidiaries

11 Baxter International Company Profile

11.1 Company Overview

11.2 Business Overview

11.2.1 BioScience

11.2.2 Medication Delivery

11.2.3 Renal

11.2.4 Products

11.2.5 History

11.3 Value Chain Analysis

11.3.1 Manufacturing

11.3.2 Product Development

11.3.3 Sales and Marketing

11.4 SWOT Analysis

11.4.1 Baxter International Inc. Strengths

11.4.2 Baxter International Inc. Weaknesses

11.4.3 Baxter International Inc. Opportunities

11.4.4 Baxter International Inc. Threats

11.5 Financial and Operational Review

11.6 Locations And Subsidiaries

11.7 Baxter International Inc. Pipeline Products

11.7.1 Next-Generation Home Hemodialysis Machine

12 Hospira, Inc. Company Profile

12.1 Company Overview

12.2 Business Overview

12.2.1 Injectable Pharmaceutical Custom Manufacturing Services Product Category

12.2.2 Other products, including critical care devices Product Category

12.2.3 Specialty Injectable Pharmaceuticals Product Category

12.2.4 Products

12.3 History

12.4 Value Chain Analysis

12.4.1 Manufacturing

12.4.2 Product Development

12.4.3 Sales and Marketing

12.5 SWOT Analysis

12.5.1 Hospira, Inc. Strengths

12.5.2 Hospira, Inc. Weaknesses

12.5.3 Hospira, Inc. Opportunities

12.5.4 Hospira, Inc. Threats

12.6 Financial and Operational Review

12.7 Locations And Subsidiaries

12.8 Other Locations & Subsidiaries

13 Regulation System

13.1 Medical Equipment Approval Process

13.1.1 Classification

13.1.2 Conformity Assessment

13.1.3 License Fee

13.1.4 License Application Processing Duration

13.2 Labeling and Packaging

13.3 Post-Market Surveillance

14 Pricing and Reimbursement

15 Distribution Structure

15.1 Distribution Structure

16 Recent Developments

16.1 Strategy And Business Planning

16.1.1 May 27, 2008: Generex Establishes Branch Office In Dubai

16.2 Product News

16.2.1 May 01, 2008: Pyng Medical Corp Receives FDA And Health Canada Clearance For Expanded Use Of FAST1

16.3 Other Significant Developments

16.3.1 Jun 10, 2008: BD Opens New Manufacturing Center In Quebec, Canada

16.4 Product Approvals

16.4.1 May 01, 2008: Pyng Medical Corp Receives FDA And Health Canada Clearance For Expanded Use Of FAST1

17 Appendix

17.1 Global Market’s Direct Research Methodology

17.2 Coverage

17.3 Secondary Research

17.4 Primary Research

17.5 Models

17.6 Forecasts

17.7 Expert Panels

17.8 Currency Conversion

17.9 Contact Us

17.10 Disclaimer

1.1 List of Tables

Table 1: Number of Physicians by Province in Canada, 2001 and 2005

Table 2: Hospital Wards by Specialty in Canada, 2003-2007

Table 3: Doctors by Specialty in Canada, 2003-2007

Table 4: Drug Delivery Devices, Canada, Overall Revenues ($ mn), 2000-2012

Table 5: Drug Delivery Devices, Canada, Overall Revenues ($ mn), Historic, 2000-2007

Table 6: Drug Delivery Devices, Canada, Overall Revenues ($ mn), Forecast, 2007-2012

Table 7: Drug Delivery Devices, Canada, Category Revenues ($ mn), 2000-2012

Table 8: Drug Delivery Devices, Canada, Category Revenues ($ mn), Historic, 2000-2007

Table 9: Drug Delivery Devices, Canada, Category Revenues ($ mn), Forecast, 2007-2012

Table 10: Drug Delivery Devices, Canada, Category Volume (Units), 2000-2012

Table 11: Drug Delivery Devices, Canada, Category Volume (Units), Historic, 2000-2007

Table 12: Drug Delivery Devices, Canada, Category Volume (Units), Forecast, 2007-2012

Table 13: Drug Delivery Devices, Canada, Company Share by Revenue ($ mn), 2005-2006

Table 14: Inhalation Systems, Canada, Overall Revenues ($ mn), Historic, 2000-2007

Table 15: Inhalation Systems, Canada, Overall Revenues ($ mn), Forecast, 2007-2012

Table 16: Inhalation Systems, Canada, Revenue by Segment ($ mn), Historic, 2000-2007

Table 17: Inhalation Systems, Canada, Revenue by Segment ($ mn), Forecast, 2007-2012

Table 18: Metered Dose Inhalation Systems, Canada, Overall Revenues ($ mn), Historic, 2000-2007

Table 19: Metered Dose Inhalation Systems, Canada, Overall Revenues ($ mn), Forecast, 2007-2012

Table 20: Dry Powder Inhaler Devices, Canada, Overall Revenues ($ mn), Historic, 2000-2007

Table 21: Dry Powder Inhaler Devices, Canada, Overall Revenues ($ mn), Forecast, 2007-2012

Table 22: Inhalation Systems, Canada, Overall Volume (Units), Historic, 2000-2007

Table 23: Inhalation Systems, Canada, Overall Volume (Units), Forecast, 2007-2012

Table 24: Metered Dose Inhalation Systems, Canada, Overall Volume (Units), Historic, 2000-2007

Table 25: Metered Dose Inhalation Systems, Canada, Overall Volume (Units), Forecast, 2007-2012

Table 26: Dry Powder Inhaler Devices, Canada, Overall Volume (Units), Historic, 2000-2007

Table 27: Dry Powder Inhaler Devices, Canada, Overall Volume (Units), Forecast, 2007-2012

Table 28: Metered Dose Inhaler Devices, Canada, Average Price ($), Historic, 2000-2007

Table 29: Metered Dose Inhaler Devices, Canada, Average Price ($), Forecast, 2007-2012

Table 30: Dry Powder Inhaler Devices, Canada, Average Price ($), Historic, 2000-2007

Table 31: Dry Powder Inhaler Devices, Canada, Average Price ($), Forecast, 2007-2012

Table 32: Inhalation Systems, Canada, Distribution Share by Revenue ($ mn), 2005-2006

Table 33: Inhalation Systems, Canada, Company Share by Revenue ($ mn), 2005-2006

Table 34: Infusion Systems, Canada, Overall Revenues ($ mn), Historic, 2000-2007

Table 35: Infusion Systems, Canada, Overall Revenues ($ mn), Forecast, 2007-2012

Table 36: Infusion Systems, Canada, Revenue by Segment ($ mn), Historic, 2000-2007

Table 37: Infusion Systems, Canada, Revenue by Segment ($ mn), Forecast, 2007-2012

Table 38: Infusion Pumps, Canada, Overall Revenues ($ mn), Historic, 2000-2007

Table 39: Infusion Pumps, Canada, Overall Revenues ($ mn), Forecast, 2007-2012

Table 40: Syringe Pumps, Canada, Overall Revenues ($ mn), Historic, 2000-2007

Table 41: Syringe Pumps, Canada, Overall Revenues ($ mn), Forecast, 2007-2012

Table 42: Infusion Disposable Sets, Canada, Overall Revenues ($ mn), Historic, 2000-2007

Table 43: Infusion Disposable Sets, Canada, Overall Revenues ($ mn), Forecast, 2007-2012

Table 44: Infusion Systems, Canada, Overall Volume (Units), Historic, 2000-2007

Table 45: Infusion Systems, Canada, Overall Volume (Units), Forecast, 2007-2012

Table 46: Infusion Pumps, Canada, Overall Volume (Units), Historic, 2000-2007

Table 47: Infusion Pumps, Canada, Overall Volume (Units), Forecast, 2007-2012

Table 48: Syringe Pumps, Canada, Overall Volume (Units), Historic, 2000-2007

Table 49: Syringe Pumps, Canada, Overall Volume (Units), Forecast, 2007-2012

Table 50: Infusion Disposable Sets, Canada, Overall Volume (Units), Historic, 2000-2007

Table 51: Infusion Disposable Sets, Canada, Overall Volume (Units), Forecast, 2007-2012

Table 52: Infusion Pumps, Canada, Average Price ($), Historic, 2000-2007

Table 53: Infusion Pumps, Canada, Average Price ($), Forecast, 2007-2012

Table 54: Syringe Pumps, Canada, Average Price ($), Historic, 2000-2007

Table 55: Syringe Pumps, Canada, Average Price ($), Forecast, 2007-2012

Table 56: Infusion Disposable Sets, Canada, Average Price ($), Historic, 2000-2007

Table 57: Infusion Disposable Sets, Canada, Average Price ($), Forecast, 2007-2012

Table 58: Infusion Systems, Canada, Distribution Share by Revenue ($ mn), 2005-2006

Table 59: Infusion Systems, Canada, Company Share by Revenue ($ mn), 2005-2006

Table 60: Needle Free Injections, Canada, Overall Revenues ($ mn), Historic, 2000-2007

Table 61: Needle Free Injections, Canada, Overall Revenues ($ mn), Forecast, 2007-2012

Table 62: Needle Free Injections, Canada, Overall Volume (Units), Historic, 2000-2007

Table 63: Needle Free Injections, Canada, Overall Volume (Units), Forecast, 2007-2012

Table 64: Needle Free Injections, Canada, Average Price ($), Historic, 2000-2007

Table 65: Needle Free Injections, Canada, Average Price ($), Forecast, 2007-2012

Table 66: Needle Free Injections, Canada, Distribution Share by Revenue ($ mn), 2005-2006

Table 67: Needle Free Injections, Canada, Company Share by Revenue ($ mn), 2005-2006

Table 68: AstraZeneca PLC, Subsidiaries

Table 69: GlaxoSmithKline plc, Subsidiaries

Table 70: 3M Company, SWOT Analysis, 2006

Table 71: 3M Company, Financial Statements, USD Million, 2002-2006

Table 72: 3M Company, Financial and Operational Overview, USD Million, 2002-2006

Table 73: 3M Company, Subsidiaries

Table 74: Baxter International Inc., SWOT Analysis, 2006

Table 75: Baxter International Inc., Financial Statements, USD Million, 2002-2006

Table 76: Baxter International Inc., Financial Ratios, USD Million, 2002-2006

Table 77: Baxter International Inc., Other Locations

Table 78: Baxter International Inc., Subsidiaries

Table 79: Hospira, Inc., SWOT Analysis, 2006

Table 80: Hospira, Inc., Financial Statements, USD Thousand, 2002-2006

Table 81: Hospira, Inc., Financial Ratios, USD Thousand, 2002-2006

Table 82: Hospira, Inc., Other Locations

Table 83: Medical Equipment Classification in Canada, 2007

Table 84: Medical Equipment Licensing Fee in Canada, 2007

Table 85: Medical Equipment License Processing Duration in Canada, 2007

Table 86: Currency Conversion from USD to Local Currency at 2007 Constant Rate 1

1.2 List of Figures

Figure 1: Healthcare Financing in Canada, 2004

Figure 2: Healthcare Expenditure in Canada, 2000 - 2006

Figure 3: Drug Delivery Devices, Canada, Overall Revenues ($ mn), 2000-2012

Figure 4: Drug Delivery Devices, Canada, Overall Revenues ($ mn), Historic, 2000-2007

Figure 5: Drug Delivery Devices, Canada, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 6: Drug Delivery Devices, Canada, Category Revenues ($ mn), 2000-2012

Figure 7: Drug Delivery Devices, Canada, Category Revenues ($ mn), Historic, 2000-2007

Figure 8: Drug Delivery Devices, Canada, Category Revenues ($ mn), Forecast, 2007-2012

Figure 9: Drug Delivery Devices, Canada, Company Share (%), 2006

Figure 10: Inhalation Systems, Canada, Overall Revenues ($ mn), Historic, 2000-2007

Figure 11: Inhalation Systems, Canada, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 12: Inhalation Systems, Canada, Revenue by Segment ($ mn), Historic, 2000-2007

Figure 13: Inhalation Systems, Canada, Revenue by Segment ($ mn), Forecast, 2007-2012

Figure 14: Metered Dose Inhalation Systems, Canada, Overall Revenues ($ mn), Historic, 2000-2007

Figure 15: Metered Dose Inhalation Systems, Canada, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 16: Dry Powder Inhaler Devices, Canada, Overall Revenues ($ mn), Historic, 2000-2007

Figure 17: Dry Powder Inhaler Devices, Canada, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 18: Inhalation Systems, Canada, Overall Volume (Units), Historic, 2000-2007

Figure 19: Inhalation Systems, Canada, Overall Volume (Units), Forecast, 2007-2012

Figure 20: Metered Dose Inhalation Systems, Canada, Overall Volume (Units), Historic, 2000-2007

Figure 21: Metered Dose Inhalation Systems, Canada, Overall Volume (Units), Forecast, 2007-2012

Figure 22: Dry Powder Inhaler Devices, Canada, Overall Volume (Units), Historic, 2000-2007

Figure 23: Dry Powder Inhaler Devices, Canada, Overall Volume (Units), Forecast, 2007-2012

Figure 24: Metered Dose Inhaler Devices, Canada, Average Price ($), Historic, 2000-2007

Figure 25: Metered Dose Inhaler Devices, Canada, Average Price ($), Forecast, 2007-2012

Figure 26: Dry Powder Inhaler Devices, Canada, Average Price ($), Historic, 2000-2007

Figure 27: Dry Powder Inhaler Devices, Canada, Average Price ($), Forecast, 2007-2012

Figure 28: Inhalation Systems, Canada, Distribution Share (%), 2006

Figure 29: Inhalation Systems, Canada, Company Share (%), 2006

Figure 30: Infusion Systems, Canada, Overall Revenues ($ mn), Historic, 2000-2007

Figure 31: Infusion Systems, Canada, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 32: Infusion Systems, Canada, Revenue by Segment ($ mn), Historic, 2000-2007

Figure 33: Infusion Systems, Canada, Revenue by Segment ($ mn), Forecast, 2007-2012

Figure 34: Infusion Pumps, Canada, Overall Revenues ($ mn), Historic, 2000-2007

Figure 35: Infusion Pumps, Canada, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 36: Syringe Pumps, Canada, Overall Revenues ($ mn), Historic, 2000-2007

Figure 37: Syringe Pumps, Canada, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 38: Infusion Disposable Sets, Canada, Overall Revenues ($ mn), Historic, 2000-2007

Figure 39: Infusion Disposable Sets, Canada, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 40: Infusion Pumps, Canada, Overall Volume (Units), Historic, 2000-2007

Figure 41: Infusion Pumps, Canada, Overall Volume (Units), Forecast, 2007-2012

Figure 42: Syringe Pumps, Canada, Overall Volume (Units), Historic, 2000-2007

Figure 43: Syringe Pumps, Canada, Overall Volume (Units), Forecast, 2007-2012

Figure 44: Infusion Disposable Sets, Canada, Overall Volume (Units), Historic, 2000-2007

Figure 45: Infusion Disposable Sets, Canada, Overall Volume (Units), Forecast, 2007-2012

Figure 46: Infusion Pumps, Canada, Average Price ($), Historic, 2000-2007

Figure 47: Infusion Pumps, Canada, Average Price ($), Forecast, 2007-2012

Figure 48: Syringe Pumps, Canada, Average Price ($), Historic, 2000-2007

Figure 49: Syringe Pumps, Canada, Average Price ($), Forecast, 2007-2012

Figure 50: Infusion Disposable Sets, Canada, Average Price ($), Historic, 2000-2007

Figure 51: Infusion Disposable Sets, Canada, Average Price ($), Forecast, 2007-2012

Figure 52: Infusion Systems, Canada, Distribution Share (%), 2006

Figure 53: Infusion Systems, Canada, Company Share (%), 2006

Figure 54: Needle Free Injections, Canada, Overall Revenues ($ mn), Historic, 2000-2007

Figure 55: Needle Free Injections, Canada, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 56: Needle Free Injections, Canada, Overall Volume (Units), Historic, 2000-2007

Figure 57: Needle Free Injections, Canada, Overall Volume (Units), Forecast, 2007-2012

Figure 58: Needle Free Injections, Canada, Average Price ($), Historic, 2000-2007

Figure 59: Needle Free Injections, Canada, Average Price ($), Forecast, 2007-2012

Figure 60: Needle Free Injections, Canada, Distribution Share (%), 2006

Figure 61: Needle Free Injections, Canada, Company Share (%), 2006

Figure 62: 3M Company, Value Chain Analysis

Figure 63: Baxter International Inc., Value Chain Analysis

Figure 64: Hospira, Inc., Value Chain Analysis

Figure 65: Global Market’s Direct Methodology

Abstract

• The report provides drug delivery devices information broken down into detailed categories and segments in Canada.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

• Gain a strong understanding of the drug delivery devices market in Canada.
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.